广东惠来，外科学博士研究生，主治医师，人力资源处处长助理。曾师从国内著名胸外科专家、食管癌和肺癌首席专家-戎铁华教授，熟练掌握食管癌和肺癌的综合治疗；师从著名胸外科专家，广东省食管癌研究所所长-傅剑华教授，熟练掌握食管癌和肺癌的微创治疗。专攻胸部肿瘤如肺癌，食管癌等手术微创治疗及综合治疗。曾多次在世界食管疾病大会、CSCO等国际国内会议作大会发言或壁报展示。 社会任职 广东省医疗行业协会胸外科管理分会委员兼副秘书长广东省药学会胸外科专业委员会委员广东省医学会肿瘤学分会生物标志学组成员广东省健康管理学会胸部肿瘤及肺结节专业委员会委员广东省基层医药学会肿瘤多学科综合诊疗专业委员会委员广州抗癌协会肿瘤支持与康复治疗专业委员会委员.广东省健康管理学会胸部肿瘤及肺结节专业委员会委员Molecular therapy （Cell子刊）、Aging、Cancer Medicine、Cancer management and research、Journal of Cardiothoracic Surgery等杂志审稿人 获奖荣誉 荣获第四届最具潜力优秀肿瘤青年医师称号以及最佳人气奖 科研成果 至今已发表国际SCI论著共23篇，其中第一作者/通讯作者15篇，包括CEBP（AACR）、BJC、ASO等著名国际肿瘤杂志。1.Zhang SS, Yang H, Luo KJ, et al. The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis. British Journal of Cancer（IF: 5.082）2013. 109(11):2894-903;2.Zhang SS, Huang QY, Yang H, et al. Correlation of p53 status with the response to chemotherapy-based treatment in esophageal cancer: A meta-analysis. Annals of Surgical Oncology (IF: 4.12) 2013 .20（7）：2419-27;3.Zhang SS, Wen Jing, Yang Fu, et al. High expression of Transient potential receptor C6 correlated with poor prognosis in patients with esophageal squamous cell carcinoma. Medical oncology（IF:2.147）.2013. 20（3）：607;4.Zhang SS, Yang Hong, Xie Xuan, et al. Adjuvant chemotherapy versus surgery-alone for esophageal squamous cell carcinoma: a meta-analysis of randomized controlled trials and nonrandomized studies. Diseases of the Esophagus (IF: 1.642) 2013. Epub ahead of print;5.Xie Xuan, Zhang SS (共同第一), Wen Jing, et al. Prognostic value of HOXB7 mRNA expression in human oesophageal squamous cell cancer.Biomarker (IF: 1.879) 2013. 18(4):297-303;6.Xie Xuan, Zhang SS (共同第一), et al. Protein Kinase D1 mRNA level May Predict Cancer-specific Survival in Heavy-smokers with Esophageal Squamous Cell Cancers. Diseases of the Esophagus(IF: 1.642) 2013. Epub ahead of print;7.Hu Wei, Liang Yayong, Zhang SS, Hu Yi, and Liu Jingeng. Impact of subcarinal dissection on short-term outcome and survival following esophagectomy. Am J Surg 2012 (IF:2.516). 2013.206(3):314-98.Zhu YH, Yang F, Zhang SS, Zeng TT, Xie X, Guan XY. High expression of biglycan is associated with poor prognosis in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol(IF：2.242). 2013 .6(11):2497-505;9.Wen J, Hu Y, Luo KJ, Yang H, Zhang SS, Fu JH.Positive transforming growth factor-β activated kinase-1 expression has an unfavorable impact on survival in T3N1-3M0 esophageal squamous cell carcinomas. Ann Thorac Surg(IF：3.741). 95(1):285-90. 2013.10.Hu W, Liang Y, Zhang SS, Hu Y, Liu J. The significance of subcarinal dissection in esophageal cancer surgery. Asia Pac J Clin Oncol (IF: 0.907). 2013 Aug 5. Epub ahead of print.11.Hu W, Liang Y, Zhang SS, Hu Y, Liu J. Ten-year survival of patients with oesophageal squamous cell carcinoma.S Afr J Surg(IF: 0.362). 2013 May 3;51(2):62-6
